©The Author(s) 2025.
World J Diabetes. Jun 15, 2025; 16(6): 105447
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105447
Published online Jun 15, 2025. doi: 10.4239/wjd.v16.i6.105447
Table 1 Baseline characteristics of study participants in relation to vaccination status, n (%)
| Variables | Categories | COVID-19 vaccination status | P value1 | Total | |
| Vaccinated, n = 57 (25.5) | Unvaccinated, n = 167 (74.5) | ||||
| Age | ≤ 40 years | 23 (28.4) | 58 (71.6) | 0.446 | 81 (36.2) |
| > 40 years | 34 (23.8) | 109 (76.2) | 143 (63.8) | ||
| Sex | Female | 29 (25.2) | 86 (74.8) | 0.936 | 115 (51.3) |
| Male | 28 (25.7) | 81 (74.3) | 109 (48.7) | ||
| Alcohol | Yes | 15 (32.6) | 31 (67.4) | 0.211 | 46 (20.5) |
| No | 42 (23.6) | 136 (76.4) | 178 (79.5) | ||
| Chat | Yes | 8 (33.3) | 16 (66.7) | 0.348 | 24 (10.7) |
| No | 49 (24.5) | 151 (75.5) | 200 (89.3) | ||
| Smoking | Yes | 3 (50.0) | 3 (50.0) | 0.174 | 6 (2.7) |
| No | 54 (24.8) | 164 (75.2) | 218 (97.3) | ||
| Medications | Insulin | 13 (23.2) | 43 (76.8) | 0.399 | 56 (25.0) |
| Metformin | 24 (22.9) | 81 (77.1) | 105 (46.9) | ||
| Both | 20 (31.8) | 43 (68.3) | 63 (28.1) | ||
- Citation: Edae CK, Bedada AT, Teklemariam MD, Girma T, Gebre SG. Longitudinal effects of Johnson & Johnson COVID-19 vaccination on metabolic biomarkers in type 2 diabetes mellitus in Ethiopia. World J Diabetes 2025; 16(6): 105447
- URL: https://www.wjgnet.com/1948-9358/full/v16/i6/105447.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i6.105447